Skip to main content
. 2013 Mar 20;8(3):e58714. doi: 10.1371/journal.pone.0058714

Figure 2. FACS isolation of CSCs (CD133+) and non-CSCs (CD133−) populations from a human squamous cell lung cancer xenograft.

Figure 2

(A) Live cells displayed distinct populations of either mouse CD45/MHC I or human EpCAM expression. (B) Isolation of human CD133+ cells (red) from human CD133− cells (green) and mouse positive cells (blue). (C) Reanalysis of cell populations in panel B shows that the C133+ cells (red) are 3.4% of the EpCAM+ population.